Company attributes
Location
B2X
Pitchbook URL
Date Incorporated
2013
Number of Employees (Ranges)
1 – 10
Full Address
1380 - 112TH AVE. NE, SUITE 200, BELLEVUE, WA, 98004
CIK Number
Investors
DUNS Number
015681733
Founded Date
2008
Total Funding Amount (USD)
2,500,000
Latest Funding Round Date
April 16, 2013
Latest Funding Type
Other attributes
Company Operating Status
Closed
BEAT BioTherapeutics is a company founded to develop novel therapies for heart disease. Its product is based on discovery in cardiac muscle contraction and the development of GeneTherapy to enhance cardiac performance in the setting of heart failure.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
